The cholinergic system, sigma-1 receptors and cognition

Behavioural Brain Research

Volumn 221, Issue 2, 2011, Pages 543-554

  Van Waarde, Aren ^a   Ramakrishnan, Nisha K ^a   Rybczynska, Anna A ^a   Elsinga, Philip H ^a   Ishiwata, Kiichi ^b   Nijholt, Ingrid M ^a   Luiten, Paul G M ^c   Dierckx, Rudi A ^a,d  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Acetylcholine; Anti amnesic effects; Cholinergic system; Cognition; Memory; Neurodegenerative disease; Sigma 1 agonists; Sigma 1 receptors

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; AMYLOID BETA PROTEIN; CHOLINESTERASE INHIBITOR; CLORGYLINE; CUTAMESINE; CYCLOSERINE; DIMEMORFAN; DONEPEZIL; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; IGMESINE; MIANSERIN; MUSCARINIC RECEPTOR; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] N METHYL 2 (1 PYRROLIDINYL)ETHYLAMINE; N ALLYLNORMETAZOCINE; N(G) NITROARGININE METHYL ESTER; PENTAZOCINE; PHYSOSTIGMINE; PIRACETAM; PRASTERONE; PROGESTERONE; RITANSERIN; SERTRALINE; SIGMA 1 OPIATE RECEPTOR; TACRINE; UNINDEXED DRUG;

ACETYLCHOLINE RELEASE; AMNESIA; BRAIN FUNCTION; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CEREBELLUM; CHOLINERGIC SYSTEM; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DRUG ACTIVITY; DRUG EFFICACY; DRUG PROTEIN BINDING; ENDOPLASMIC RETICULUM; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; MEMORY DISORDER; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ACETYLCHOLINE; AGING; ANIMALS; BRAIN; CALCIUM; CELL DIFFERENTIATION; CHOLINERGIC FIBERS; COGNITION; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; HUMANS; N-METHYLASPARTATE; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; NEURONS; PSYCHOTROPIC DRUGS; RECEPTORS, SIGMA;

EID: 79955719661     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.12.043     Document Type: Review

References (163)

1. Aigner T.G. Pharmacology of memory: cholinergic-glutamatergic interactions. Curr Opin Neurobiol 1995, 5:155-160.
2. Antonini V., Prezzavento O., Coradazzi M., Marrazzo A., Ronsisvalle S., Arena E., et al. Anti-amnesic properties of (+/-)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats. J Neurochem 2009, 109:744-754.
3. Artola A., Singer W. Long-term potentiation and NMDA receptors in rat visual cortex. Nature 1987, 330:649-652.
4. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-414.
5. Bergeron R., de Montigny C., Debonnel G. Biphasic effects of sigma ligands on the neuronal response to N-methyl-d-aspartate. Naunyn Schmiedebergs Arch Pharmacol 1995, 351:252-260.
6. Bergeron R., de Montigny C., Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 1996, 16:1193-1202.
7. Bergeron R., de Montigny C., Debonnel G. Pregnancy reduces brain sigma receptor function. Br J Pharmacol 1999, 127:1769-1776.
8. Bergeron R., Debonnel G., de Montigny C. Modification of the N-methyl-d-aspartate response by antidepressant sigma receptor ligands. Eur J Pharmacol 1993, 240:319-323.
9. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
10. Brown A.W., Aldridge W.N., Street B.W., Verschoyle R.D. The behavioral and neuropathologic sequelae of intoxication by trimethyltin compounds in the rat. Am J Pathol 1979, 97:59-82.
11. Chang L.W., Dyer R.S. A time-course study of trimethyltin induced neuropathology in rats. Neurobehav Toxicol Teratol 1983, 5:443-459.
12. Chen L., Dai X.N., Sokabe M. Chronic administration of dehydroepiandrosterone sulfate (DHEAS) primes for facilitated induction of long-term potentiation via sigma 1 (sigma1) receptor: optical imaging study in rat hippocampal slices. Neuropharmacology 2006, 50:380-392.
13. Cobos E.J., Entrena J.M., Nieto F.R., Cendan C.M., Del Pozo E. Pharmacology and therapeutic potential of sigma(1) receptor ligands. Curr Neuropharmacol 2008, 6:344-366.
14. Collier T.L., Waterhouse R.N., Kassiou M. Imaging sigma receptors: applications in drug development. Curr Pharm Des 2007, 13:51-72.
15. Collingridge G. Synaptic plasticity. The role of NMDA receptors in learning and memory. Nature 1987, 330:604-605.
16. Cory-Slechta D.A. The impact of NMDA receptor antagonists on learning and memory functions. Psychopharmacol Bull 1994, 30:601-612.
17. Couture S., Debonnel G. Modulation of the neuronal response to N-methyl-d-aspartate by selective sigma2 ligands. Synapse 1998, 29:62-71.
18. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983, 219:1184-1190.
19. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
20. Debonnel G., Bergeron R., de Montigny C. Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-d-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors. J Endocrinol 1996, 150(Suppl.):S33-S42.
21. Debonnel G., Bergeron R., Monnet F.P., de Montigny C. Differential effects of sigma ligands on the N-methyl-d-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning. Neuroscience 1996, 71:977-987.
22. Demerens C., Stankoff B., Zalc B., Lubetzki C. Eliprodil stimulates CNS myelination: new prospects for multiple sclerosis?. Neurology 1999, 52:346-350.
23. Dong L.Y., Cheng Z.X., Fu Y.M., Wang Z.M., Zhu Y.H., Sun J.L., et al. Neurosteroid dehydroepiandrosterone sulfate enhances spontaneous glutamate release in rat prelimbic cortex through activation of dopamine D1 and sigma-1 receptor. Neuropharmacology 2007, 52:966-974.
24. Dong Y., Fu Y.M., Sun J.L., Zhu Y.H., Sun F.Y., Zheng P. Neurosteroid enhances glutamate release in rat prelimbic cortex via activation of alpha1-adrenergic and sigma1 receptors. Cell Mol Life Sci 2005, 62:1003-1014.
25. Earley B., Burke M., Leonard B.E., Gouret C.J., Junien J.L. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor. Brain Res 1991, 546:282-286.
26. Ela C., Barg J., Vogel Z., Hasin Y., Eilam Y. Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 1994, 269:1300-1309.
27. Espallergues J., Lapalud P., Christopoulos A., Avlani V.A., Sexton P.M., Vamvakides A., et al. Involvement of the sigma1 (sigma1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41. Br J Pharmacol 2007, 152:267-279.
28. Gallagher M., Colombo P.J. Ageing: the cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol 1995, 5:161-168.
29. Hall A.A., Herrera Y., Ajmo C.T., Cuevas J., Pennypacker K.R. Sigma receptors suppress multiple aspects of microglial activation. Glia 2008, 57:744-754.
30. Harris E.W., Ganong A.H., Cotman C.W. Long-term potentiation in the hippocampus involves activation of N-methyl-d-aspartate receptors. Brain Res 1984, 323:132-137.
31. Hashimoto K., Fujita Y., Iyo M. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors. Neuropsychopharmacology 2007, 32:514-521.
32. Hashimoto K., Ishiwata K. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. Curr Pharm Des 2006, 12:3857-3876.
33. Hayashi T., Kagaya A., Takebayashi M., Shimizu M., Uchitomi Y., Motohashi N., et al. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-d-aspartate in primary culture of rat frontal cortical neurons. J Pharmacol Exp Ther 1995, 275:207-214.
34. Hayashi T., Maurice T., Su T.P. Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. J Pharmacol Exp Ther 2000, 293:788-798.
35. Hayashi T., Su T. The sigma receptor: evolution of the concept in neuropsychopharmacology. Curr Neuropharmacol 2005, 3:267-280.
36. Hayashi T., Su T.P. Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells. J Pharmacol Exp Ther 2003, 306:726-733.
37. Hayashi T., Su T.P. Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc Natl Acad Sci USA 2004, 101:14949-14954.
38. Hayashi T., Su T.P. The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse. Life Sci 2005, 77:1612-1624.
39. Hayashi T., Su T.P. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 2007, 131:596-610.
40. Hayashi T., Su T.P. An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma(1) receptor ligand. Expert Opin Ther Targets 2008, 12:45-58.
41. Hiramatsu M., Hoshino T. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy. Brain Res 2004, 1030:247-255.
42. Hiramatsu M., Hoshino T. Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors. Brain Res 2005, 1057:72-80.
43. Hiramatsu M., Hoshino T., Kameyama T., Nabeshima T. Involvement of kappa-opioid and sigma receptors in short-term memory in mice. Eur J Pharmacol 2002, 453:91-98.
44. Hong W., Nuwayhid S.J., Werling L.L. Modulation of bradykinin-induced calcium changes in SH-SY5Y cells by neurosteroids and sigma receptor ligands via a shared mechanism. Synapse 2004, 54:102-110.
45. Horan B., Gifford A.N., Matsuno K., Mita S., Ashby C.R. Effect of SA4503 on the electrically evoked release of 3H-acetylcholine from striatal and hippocampal rat brain slices. Synapse 2002, 46:1-3.
46. Inoue M., Suhara T., Sudo Y., Okubo Y., Yasuno F., Kishimoto T., et al. Age-related reduction of extrastriatal dopamine D2 receptor measured by PET. Life Sci 2001, 69:1079-1084.
47. Ishii K., Kimura Y., Kawamura K., Oda K., Sasaki T., Ishiwata K. Mapping of sigma1 receptors by 11C-SA4503-distribution and aging effect in normal human brain. Neuroimage 2002, 16:S31. [abstract].
48. Ishikawa M., Ishiwata K., Ishii K., Kimura Y., Sakata M., Naganawa M., et al. High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [(11)C]SA4503. Biol Psychiatry 2007, 62:878-883.
49. Ishikawa M., Sakata M., Ishii K., Kimura Y., Oda K., Toyohara J., et al. High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503. Int J Neuropsychopharmacol 2009, 12:1127-1131.
50. Ishima T., Nishimura T., Iyo M., Hashimoto K. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP(3) receptors. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1656-1659.
51. Ishiwata K., Kobayashi T., Kawamura K., Matsuno K. Age-related changes of the binding of [3h]SA4503 to sigma1 receptors in the rat brain. Ann Nucl Med 2003, 17:73-77.
52. Itzhak Y., Stein I., Zhang S.H., Kassim C.O., Cristante D. Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes. J Pharmacol Exp Ther 1991, 257:141-148.
53. Ivkovic M., Damjanovic A., Jasovic-Gasic M., Paunovic V.R. The effects of fluoxetine on cognitive functions in animal model of Alzheimer's disease. Psychiatr Danub 2004, 16:15-20.
54. Iyo M., Shirayama Y., Watanabe H., Fujisaki M., Miyatake R., Fukami G., et al. Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1072-1073.
55. Izquierdo I. Role of NMDA receptors in memory. Trends Pharmacol Sci 1991, 12:128-129.
56. Jansen K.L., Faull R.L., Storey P., Leslie R.A. Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss. Brain Res 1993, 623:299-302.
57. Jiang G., Mysona B., Dun Y., Gnana-Prakasam J.P., Pabla N., Li W., et al. Expression, subcellular localization, and regulation of sigma receptor in retinal muller cells. Invest Ophthalmol Vis Sci 2006, 47:5576-5582.
58. Junien J.L., Roman F.J., Brunelle G., Pascaud X. JO1784, a novel sigma ligand, potentiates [3H]acetylcholine release from rat hippocampal slices. Eur J Pharmacol 1991, 200:343-345.
59. Kato K., Hayako H., Ishihara Y., Marui S., Iwane M., Miyamoto M. TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons. Neurosci Lett 1999, 260:5-8.
60. Kawamura K., Kimura Y., Tsukada H., Kobayashi T., Nishiyama S., Kakiuchi T., et al. An increase of sigma receptors in the aged monkey brain. Neurobiol Aging 2003, 24:745-752.
61. Klette K.L., Lin Y., Clapp L.E., DeCoster M.A., Moreton J.E., Tortella F.C. Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons. Brain Res 1997, 756:231-240.
62. Kobayashi T., Matsuno K., Mita S. Regional differences of the effect of sigma receptor ligands on the acetylcholine release in the rat brain. J Neural Transm Gen Sect 1996, 103:661-669.
63. Kobayashi T., Matsuno K., Nakata K., Mita S. Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain. J Pharmacol Exp Ther 1996, 279:106-113.
64. Krall W.J., Sramek J.J., Cutler N.R. Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease. Ann Pharmacother 1999, 33:441-450.
65. Kunitachi S., Fujita Y., Ishima T., Kohno M., Horio M., Tanibuchi Y., et al. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors. Brain Res 2009, 1279:189-196.
66. Liang X., Wang R.Y. Biphasic modulatory action of the selective sigma receptor ligand SR 31742A on N-methyl-d-aspartate-induced neuronal responses in the frontal cortex. Brain Res 1998, 807:208-213.
67. Lucas G., Rymar V.V., Sadikot A.F., Debonnel G. Further evidence for an antidepressant potential of the selective sigma1 agonist SA 4503: electrophysiological, morphological and behavioural studies. Int J Neuropsychopharmacol 2008, 11:485-495.
68. Lynch M.A. Long-term potentiation and memory. Physiol Rev 2004, 84:87-136.
69. Majewska M.D., Parameswaran S., Vu T., London E.D. Divergent ontogeny of sigma and phencyclidine binding sites in the rat brain. Brain Res Dev Brain Res 1989, 47:13-18.
70. Mamiya T., Noda Y., Noda A., Hiramatsu M., Karasawa K., Kameyama T., et al. Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice. Neuropharmacology 2000, 39:2391-2398.
71. Marrazzo A., Caraci F., Salinaro E.T., Su T.P., Copani A., Ronsisvalle G. Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity. Neuroreport 2005, 16:1223-1226.
72. Martina M., Turcotte M.E., Halman S., Bergeron R. The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol 2007, 578:143-157.
73. Maruszak A., Safranow K., Gacia M., Gabryelewicz T., Slowik A., Styczynska M., et al. Sigma receptor type 1 gene variation in a group of polish patients with Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2007, 23:432-438.
74. Matsumoto R.R., Bowen W.D., Walker J.M. Age-related differences in the sensitivity of rats to a selective sigma ligand. Brain Res 1989, 504:145-148.
75. Matsuno K., Matsunaga K., Mita S. Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis. Brain Res 1992, 575:315-319.
76. Matsuno K., Matsunaga K., Senda T., Mita S. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. J Pharmacol Exp Ther 1993, 265:851-859.
77. Matsuno K., Senda T., Kobayashi T., Mita S. Involvement of sigma 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats. Brain Res 1995, 690:200-206.
78. Matsuno K., Senda T., Kobayashi T., Murai M., Mita S. Reduction of 4-cyclohexyl-1-[(1R)-1,2-diphenylethyl]-piperazine-induced memory impairment of passive avoidance performance by sigma 1 receptor agonists in mice. Methods Find Exp Clin Pharmacol 1998, 20:575-580.
79. Matsuno K., Senda T., Kobayashi T., Okamoto K., Nakata K., Mita S. SA4503, a novel cognitive enhancer, with sigma-1 receptor agonistic properties. Behav Brain Res 1997, 83:221-224.
80. Matsuno K., Senda T., Matsunaga K., Mita S. Ameliorating effects of sigma receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system. Eur J Pharmacol 1994, 261:43-51.
81. Matsuno K., Senda T., Matsunaga K., Mita S., Kaneto H. Similar ameliorating effects of benzomorphans and 5-HT2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors. Psychopharmacology (Berl) 1993, 112:134-141.
82. Maurice T. Beneficial effect of the sigma(1) receptor agonist PRE-084 against the spatial learning deficits in aged rats. Eur J Pharmacol 2001, 431:223-227.
83. Maurice T. Improving Alzheimer's disease-related cognitive deficits with sigma1 receptor agonists. Drug News Perspect 2002, 15:617-625.
84. Maurice T. Neurosteroids and sigma1 receptors, biochemical and behavioral relevance. Pharmacopsychiatry 2004, 37(Suppl. 3):S171-S182.
85. Maurice T. Cognitive effects of sigma-receptor ligands. Sigma receptors: chemistry, cell biology and clinical implication 2007, 237-271. Springer, New York, [Chapter 12]. R.R. Matsumoto, W.D. Bowen, T.P. Su (Eds.).
86. Maurice T., Hiramatsu M., Itoh J., Kameyama T., Hasegawa T., Nabeshima T. Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res 1994, 647:44-56.
87. Maurice T., Hiramatsu M., Kameyama T., Hasegawa T., Nabeshima T. Behavioral evidence for a modulating role of sigma ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia. Brain Res 1994, 647:57-64.
88. Maurice T., Junien J.L., Privat A. Dehydroepiandrosterone sulfate attenuates dizocilipine-induced learning impairment in mice via sigma-1 receptors. Behav Brain Res 1997, 83:159-164.
89. Maurice T., Lockhart B.P. Neuroprotective and anti-amnesic potentials of sigma receptor ligands. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:69-102.
90. Maurice T., Meunier J., Feng B., Ieni J., Monaghan D.T. Interaction with sigma(1) protein, but not N-methyl-d-aspartate receptor, is involved in the pharmacological activity of donepezil. J Pharmacol Exp Ther 2006, 317:606-614.
91. Maurice T., Phan V., Sandillon F., Urani A. Differential effect of dehydroepiandrosterone and its steroid precursor pregnenolone against the behavioural deficits in CO-exposed mice. Eur J Pharmacol 2000, 390:145-155.
92. Maurice T., Phan V.L., Noda Y., Yamada K., Privat A., Nabeshima T. The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites. Br J Pharmacol 1999, 127:335-342.
93. Maurice T., Phan V.L., Privat A. The anti-amnesic effects of sigma1 (sigma1) receptor agonists confirmed by in vivo antisense strategy in the mouse. Brain Res 2001, 898:113-121.
94. Maurice T., Phan V.L., Urani A., Guillemain I. Differential involvement of the sigma(1) (sigma(1)) receptor in the anti-amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse. Br J Pharmacol 2001, 134:1731-1741.
95. Maurice T., Phan V.L., Urani A., Kamei H., Noda Y., Nabeshima T. Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol 1999, 81:125-155.
96. Maurice T., Privat A. SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA-receptor-dependent learning in mice. Eur J Pharmacol 1997, 328:9-18.
97. Maurice T., Roman F.J., Su T.P., Privat A. Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM). Brain Res 1996, 733:219-230.
98. Maurice T., Su T.P. The pharmacology of sigma-1 receptors. Pharmacol Ther 2009, 124:195-206.
99. Maurice T., Su T.P., Parish D.W., Privat A. Prevention of nimodipine-induced impairment of learning by the selective sigma ligand PRE-084. J Neural Transm Gen Sect 1995, 102:1-18.
100. Maurice T., Su T.P., Privat A. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 1998, 83:413-428.
101. Maurice T., Urani A., Phan V.L., Romieu P. The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res Brain Res Rev 2001, 37:116-132.
102. McCann D.J., Su T.P. Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions. Eur J Pharmacol 1990, 188:211-218.
103. Meunier J., Gue M., Recasens M., Maurice T. Attenuation by a sigma1 (sigma1) receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats. Br J Pharmacol 2004, 142:689-700.
104. Meunier J., Ieni J., Maurice T. Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas. J Pharmacol Exp Ther 2006, 317:1307-1319.
105. Meunier J., Ieni J., Maurice T. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta(25-35) peptide-induced toxicity in mice involve an interaction with the sigma(1) receptor. Br J Pharmacol 2006, 149:998-1012.
106. Meunier J., Maurice T. Beneficial effects of the sigma1 receptor agonists igmesine and dehydroepiandrosterone against learning impairments in rats prenatally exposed to cocaine. Neurotoxicol Teratol 2004, 26:783-797.
107. Meyer D.A., Carta M., Partridge L.D., Covey D.F., Valenzuela C.F. Neurosteroids enhance spontaneous glutamate release in hippocampal neurons - possible role of metabotropic sigma(1)-like receptors. J Biol Chem 2002, 277:28725-28732.
108. Mishina M., Ishiwata K., Ishii K., Kitamura S., Kimura Y., Kawamura K., et al. Function of sigma1 receptors in Parkinson's disease. Acta Neurol Scand 2005, 112:103-107.
109. Mishina M., Ohyama M., Ishii K., Kitamura S., Kimura Y., Oda K., et al. Low density of sigma1 receptors in early Alzheimer's disease. Ann Nucl Med 2008, 22:151-156.
110. Monnet F.P. Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance. Biol Cell 2005, 97:873-883.
111. Monnet F.P., de Costa B.R., Bowen W.D. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. Br J Pharmacol 1996, 119:65-72.
112. Monnet F.P., Debonnel G., de Montigny C. In vivo electrophysiological evidence for a selective modulation of N-methyl-d-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. J Pharmacol Exp Ther 1992, 261:123-130.
113. Monnet F.P., Debonnel G., Fournier A., de Montigny C. Neuropeptide Y potentiates the N-methyl-d-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor. J Pharmacol Exp Ther 1992, 263:1219-1225.
114. Monnet F.P., Debonnel G., Junien J.L., de Montigny C. N-methyl-d-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol 1990, 179:441-445.
115. Monnet F.P., Morin-Surun M.P., Leger J., Combettes L. Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons. J Pharmacol Exp Ther 2003, 307:705-712.
116. Morin-Surun M.P., Collin T., Denavit-Saubie M., Baulieu E.E., Monnet F.P. Intracellular sigma(1) receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Natl Acad Sci USA 1999, 96:8196-8199.
117. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5. Nature 1986, 319:774-776.
118. Nabeshima T., Katoh A., Ishimaru H., Yoneda Y., Ogita K., Murase K., et al. Carbon monoxide-induced delayed amnesia, delayed neuronal death and change in acetylcholine concentration in mice. J Pharmacol Exp Ther 1991, 256:378-384.
119. Narita N., Hashimoto K., Tomitaka S., Minabe Y. Interactions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain. Eur J Pharmacol 1996, 307:117-119.
120. Nishimura T., Ishima T., Iyo M., Hashimoto K. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS ONE 2008, 3:e2558.
121. Noda A., Noda Y., Kamei H., Ichihara K., Mamiya T., Nagai T., et al. Phencyclidine impairs latent learning in mice: interaction between glutamatergic systems and sigma(1) receptors. Neuropsychopharmacology 2001, 24:451-460.
122. Norbury R., Travis M.J., Erlandsson K., Waddington W., Owens J., Pimlott S., et al. In vivo imaging of muscarinic receptors in the aging female brain with (R,R)[123I]-I-QNB and single photon emission tomography. Exp Gerontol 2005, 40:137-145.
123. Novakova M., Ela C., Bowen W.D., Hasin Y., Eilam Y. Highly selective sigma receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes. Eur J Pharmacol 1998, 353:315-327.
124. O'Connell A.W., Earley B., Leonard B.E. The sigma ligand JO 1784 prevents trimethyltin-induced behavioural and sigma-receptor dysfunction in the rat. Pharmacol Toxicol 1996, 78:296-302.
125. Oda T., Kume T., Katsuki H., Niidome T., Sugimoto H., Akaike A. Donepezil potentiates nerve growth factor-induced neurite outgrowth in PC12 cells. J Pharmacol Sci 2007, 104:349-354.
126. Ohno M., Watanabe S. Intrahippocampal administration of (+)-SKF 10,047, a sigma ligand, reverses MK-801-induced impairment of working memory in rats. Brain Res 1995, 684:237-242.
127. Palacios G., Muro A., Vela J.M., Molina-Holgado E., Guitart X., Ovalle S., et al. Immunohistochemical localization of the sigma1-receptor in oligodendrocytes in the rat central nervous system. Brain Res 2003, 961:92-99.
128. Palacios G., Muro A., Verdu E., Pumarola M., Vela J.M. Immunohistochemical localization of the sigma1 receptor in Schwann cells of rat sciatic nerve. Brain Res 2004, 1007:65-70.
129. Paleos G.A., Yang Z.W., Byrd J.C. Ontogeny of PCP and sigma receptors in rat brain. Brain Res Dev Brain Res 1990, 51:147-152.
130. Parada-Turska J., Turski W.A. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-d-aspartate receptors in learning and memory tasks. Neuropharmacology 1990, 29:1111-1116.
131. Patel S., Tariot P.N. Pharmacologic models of Alzheimer's disease. Psychiatr Clin North Am 1991, 14:287-308.
132. Phan V.L., Miyamoto Y., Nabeshima T., Maurice T. Age-related expression of sigma1 receptors and antidepressant efficacy of a selective agonist in the senescence-accelerated (SAM) mouse. J Neurosci Res 2005, 79:561-572.
133. Phan V.L., Urani A., Sandillon F., Privat A., Maurice T. Preserved sigma1 (sigma1) receptor expression and behavioral efficacy in the aged C57BL/6 mouse. Neurobiol Aging 2003, 24:865-881.
134. Ramachandran S., Chu U.B., Mavlyutov T.A., Pal A., Pyne S., Ruoho A.E. The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. Eur J Pharmacol 2009, 609:19-26.
135. Reddy D.S., Kulkarni S.K. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res 1998, 791:108-116.
136. Sabeti J., Nelson T.E., Purdy R.H., Gruol D.L. Steroid pregnenolone sulfate enhances NMDA-receptor-independent long-term potentiation at hippocampal CA1 synapses: role for L-type calcium channels and sigma-receptors. Hippocampus 2007, 17:349-369.
137. Samovilova N.N., Vinogradov V.A. Subcellular distribution of (+)-[3H]SKF 10,047 binding sites in rat liver. Eur J Pharmacol 1992, 225:69-74.
138. Schiess A.R., Partridge L.D. Pregnenolone sulfate acts through a G-protein-coupled sigma1-like receptor to enhance short term facilitation in adult hippocampal neurons. Eur J Pharmacol 2005, 518:22-29.
139. Senda T., Matsuno K., Kobayashi T., Mita S. Reduction of the scopolamine-induced impairment of passive-avoidance performance by sigma receptor agonist in mice. Physiol Behav 1997, 61:257-264.
140. Senda T., Matsuno K., Kobayashi T., Nakazawa M., Nakata K., Mita S. Ameliorative effect of SA4503, a novel cognitive enhancer, on the basal forebrain lesion-induced impairment of the spatial learning performance in rats. Pharmacol Biochem Behav 1998, 59:129-134.
141. Senda T., Matsuno K., Okamoto K., Kobayashi T., Nakata K., Mita S. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol 1996, 315:1-10.
142. Sheline Y.I., Mintun M.A., Moerlein S.M., Snyder A.Z. Greater loss of 5-HT(2A) receptors in midlife than in late life. Am J Psychiatry 2002, 159:430-435.
143. Su T.P., London E.D., Jaffe J.H. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 1988, 240:219-221. [see comments].
144. Takebayashi M., Hayashi T., Su T.P. Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants. J Pharmacol Exp Ther 2002, 303:1227-1237.
145. Takebayashi M., Hayashi T., Su T.P. A perspective on the new mechanism of antidepressants: neuritogenesis through sigma-1 receptors. Pharmacopsychiatry 2004, 37(Suppl. 3):S208-S213.
146. Takebayashi M., Hayashi T., Su T.P. sigma-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution. Synapse 2004, 53:90-103.
147. Teyler T.J. Long-term potentiation and memory. Int J Neurol 1987, 21-22:163-171.
148. Tottori K., Nakai M., Uwahodo Y., Miwa T., Yamada S., Oshiro Y., et al. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate). J Pharmacol Exp Ther 2002, 301:249-257.
149. Tsai S.Y., Hayashi T., Su T.P. Hippocampal dendritogenesis and associated anchoring of NMDA and AMPA receptors are controlled by sigma-1 receptors. Int J Neuropsychopharmacol 2006, 9:S213. [abstract].
150. Tsien J.Z., Huerta P.T., Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 1996, 87:1327-1338.
151. Uchida N., Ujike H., Tanaka Y., Sakai A., Yamamoto M., Fujisawa Y., et al. A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease. Am J Geriatr Psychiatry 2005, 13:1062-1066.
152. Urani A., Privat A., Maurice T. The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (sigma1) receptors. Brain Res 1998, 799:64-77.
153. Urani A., Romieu P., Portales-Casamar E., Roman F.J., Maurice T. The antidepressant-like effect induced by the sigma(1) (sigma(1)) receptor agonist igmesine involves modulation of intracellular calcium mobilization. Psychopharmacology (Berl) 2002, 163:26-35.
154. Urani A., Romieu P., Roman F.J., Maurice T. Enhanced antidepressant effect of sigma(1) (sigma(1)) receptor agonists in beta(25-35)-amyloid peptide-treated mice. Behav Brain Res 2002, 134:239-247.
155. Urani A., Romieu P., Roman F.J., Yamada K., Noda Y., Kamei H., et al. Enhanced antidepressant efficacy of sigma1 receptor agonists in rats after chronic intracerebroventricular infusion of beta-amyloid-(1-40) protein. Eur J Pharmacol 2004, 486:151-161.
156. Venable N., Kelly P.H. Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice. Psychopharmacology (Berl) 1990, 100:215-221.
157. Villard V., Espallergues J., Keller E., Alkam T., Nitta A., Yamada K., et al. Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice. Neuropsychopharmacology 2009, 34:1552-1566.
158. Wang H.H., Chien J.W., Chou Y.C., Liao J.F., Chen C.F. Anti-amnesic effect of dimemorfan in mice. Br J Pharmacol 2003, 138:941-949.
159. Wu Z., Bowen W.D. Role of sigma-1 receptor C-terminal segment in IP3 receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells. J Biol Chem 2008, 283:28198-28215.
160. Yagasaki Y., Numakawa T., Kumamaru E., Hayashi T., Su T.P., Kunugi H. Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. J Biol Chem 2006, 281:12941-12949.
161. Yeh L.A., Padmanaban D., Ho P., Xing X., Rowley P., Morse L.J., et al. Effects of a verbenachalcone derivative on neurite outgrowth, inhibition of caspase induction and gene expression. Bioorg Med Chem Lett 2005, 15:1193-1196.
162. Zou L., Yamada K., Sasa M., Nakata Y., Nabeshima T. Effects of sigma(1) receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats. Neuropharmacology 2000, 39:1617-1627.
163. Zou L.B., Yamada K., Nabeshima T. Sigma receptor ligands (+)-SKF10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats. Eur J Pharmacol 1998, 355:1-10.